Cytokine-Induced Memory-Like Differentiation Enhances Unlicensed Natural Killer Cell Antileukemia and FcγRIIIa-Triggered Responses  Julia A. Wagner, Melissa.

Slides:



Advertisements
Similar presentations
Characterization of Cord Blood Natural Killer and Lymphokine Activated Killer Lymphocytes Following Ex Vivo Cellular Engineering  Janet Ayello, Carmella.
Advertisements

Engineering Human Peripheral Blood Stem Cell Grafts that Are Depleted of Naïve T Cells and Retain Functional Pathogen-Specific Memory T Cells  Marie Bleakley,
Blood Dendritic Cells Suppress NK Cell Function and Increase the Risk of Leukemia Relapse after Hematopoietic Cell Transplantation  Antonio Perez-Martinez,
Depletion of Alloreactive Donor T Lymphocytes by CD95-Mediated Activation-Induced Cell Death Retains Antileukemic, Antiviral, and Immunoregulatory T Cell.
Role of Natural Killer Cells in Intravenous Immunoglobulin–Induced Graft-versus-Host Disease Inhibition in NOD/LtSz-scidIL2rg−/− (NSG) Mice  Joëlle Gregoire-Gauthier,
Juyang Kim, Wongyoung Kim, Hyun J. Kim, Sohye Park, Hyun-A
Krystel Vincent, Marie-Pierre Hardy, Assya Trofimov, Céline M
Expansion of NKG2A−LIR1− Natural Killer Cells in HLA-Matched, Killer Cell Immunoglobulin-Like Receptors/HLA-Ligand Mismatched Patients following Hematopoietic.
Induction of Immunity to Neuroblastoma Early after Syngeneic Hematopoietic Stem Cell Transplantation Using a Novel Mouse Tumor Vaccine  Weiqing Jing,
Ping Zhang, Jieying Wu, Divino Deoliveira, Nelson J. Chao, Benny J
Apoptotic Donor Leukocytes Limit Mixed-Chimerism Induced by CD40-CD154 Blockade in Allogeneic Bone Marrow Transplantation  Jian-ming Li, John Gorechlad,
Human NK cell development in NOD/SCID mice receiving grafts of cord blood CD34+ cells by Christian P. Kalberer, Uwe Siegler, and Aleksandra Wodnar-Filipowicz.
Suzanne L. Tomchuck, Wing H. Leung, Mari H. Dallas 
Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion by Yenan T. Bryceson, Michael E. March, Hans-Gustaf.
CD20-Targeted T Cells after Stem Cell Transplantation for High Risk and Refractory Non-Hodgkin's Lymphoma  Lawrence G. Lum, Archana Thakur, Qin Liu, Abhinav.
Rapid, Flow Cytometric Assay for NK Alloreactivity Reveals Exceptions to Rules Governing Alloreactivity  Dianne De Santis, Bree A. Foley, Elisabeth John,
Ex Vivo Rapamycin Generates Th1/Tc1 or Th2/Tc2 Effector T Cells With Enhanced In Vivo Function and Differential Sensitivity to Post-transplant Rapamycin.
Altered Homeostasis of CD4+ Memory T Cells in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Chronic Graft-versus-Host Disease Enhances T Cell.
Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer.
Effects of the NK Cell Recovery on Outcomes of Unmanipulated Haploidentical Blood and Marrow Transplantation for Patients with Hematologic Malignancies 
Volume 138, Issue 5, Pages e2 (May 2010)
Up-regulation of NK Cell Activating Receptors Following Allogeneic Hematopoietic Stem Cell Transplantation under a Lymphodepleting Reduced Intensity Regimen.
Mycophenolic Acid Inhibits Natural Killer Cell Proliferation and Cytotoxic Function: A Possible Disadvantage of Including Mycophenolate Mofetil in the.
Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia  Guenther.
Growth and Differentiation Advantages of CD4+OX40+ T Cells from Allogeneic Hematopoietic Stem Cell Transplantation Recipients  Takero Shindo, Takayuki.
Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences.
FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides.
CD134-Allodepletion Allows Selective Elimination of Alloreactive Human T Cells without Loss of Virus-Specific and Leukemia-Specific Effectors  Xupeng.
Blood Dendritic Cells Suppress NK Cell Function and Increase the Risk of Leukemia Relapse after Hematopoietic Cell Transplantation  Antonio Perez-Martinez,
Volume 20, Issue 12, Pages (September 2017)
Cytomegalovirus-Specific Cytotoxic T Lymphocytes Can Be Efficiently Expanded from Granulocyte Colony-Stimulating Factor–Mobilized Hemopoietic Progenitor.
Virally infected and matured human dendritic cells activate natural killer cells via cooperative activity of plasma membrane-bound TNF and IL-15 by Lazar.
Generation of Highly Cytotoxic Natural Killer Cells for Treatment of Acute Myelogenous Leukemia Using a Feeder-Free, Particle-Based Approach  Jeremiah.
Volume 138, Issue 4, Pages (April 2010)
Reconstitution of Natural Killer Cells in HLA-Matched HSCT after Reduced-Intensity Conditioning: Impact on Clinical Outcome  Caroline Pical-Izard, Roberto.
Adoptive Therapy with T Cells/NK Cells
Natural Killer Cell Differentiation from Hematopoietic Stem Cells: A Comparative Analysis of Heparin- and Stromal Cell–Supported Methods  Steven A. Dezell,
Combination Therapy Using IL-2 and Anti-CD25 Results in Augmented Natural Killer Cell–Mediated Antitumor Responses  William H.D. Hallett, Erik Ames, Maite.
Homeostatic γδ T Cell Contents Are Preserved by Granulocyte Colony-Stimulating Factor Priming and Correlate with the Early Recovery of γδ T Cell Subsets.
Xinchun Chen, Yi Zeng, Gang Li, Nicolas Larmonier, Michael W
Human NK Cell Education by Inhibitory Receptors for MHC Class I
Expansion of NKG2A−LIR1− Natural Killer Cells in HLA-Matched, Killer Cell Immunoglobulin-Like Receptors/HLA-Ligand Mismatched Patients following Hematopoietic.
Kathleen R. Bartemes, BA, Gail M. Kephart, BS, Stephanie J
T helper17 Cells Are Sufficient But Not Necessary to Induce Acute Graft-Versus-Host Disease  Cristina Iclozan, Yu Yu, Chen Liu, Yaming Liang, Tangsheng.
Cytolytic Pathways Used by Effector Cells Derived from Recipient Naive and Memory T Cells and Natural Killer Cells in Resistance to Allogeneic Hematopoietic.
Lisa A. Palmer, George E. Sale, John I
Quantity and Quality Reconstitution of NKG2A+ Natural Killer Cells Are Associated with Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation 
Natural Killer Cell Killing of Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia Blasts by Killer Cell Immunoglobulin-Like Receptor–Negative.
Host Basophils Are Dispensable for Induction of Donor T Helper 2 Cell Differentiation and Severity of Experimental Graft-versus-Host Disease  Isao Tawara,
Characterization of Cord Blood Natural Killer and Lymphokine Activated Killer Lymphocytes Following Ex Vivo Cellular Engineering  Janet Ayello, Carmella.
A Radio-Resistant Perforin-Expressing Lymphoid Population Controls Allogeneic T Cell Engraftment, Activation, and Onset of Graft-versus-Host Disease in.
Circulating Natural Killer Lymphocytes Are Potential Cytotoxic Effectors Against Autologous Malignant Cells in Sezary Syndrome Patients  Jean-David Bouaziz,
Laurent Boissel, Hande H
Donor Selection in T Cell–Replete Haploidentical Hematopoietic Stem Cell Transplantation: Knowns, Unknowns, and Controversies  Stefan O. Ciurea, Richard.
Dichotomous Role of Interferon-γ in Allogeneic Bone Marrow Transplant
Activated Notch Supports Development of Cytokine Producing NK Cells Which Are Hyporesponsive and Fail to Acquire NK Cell Effector Functions  Veronika.
Volume 24, Issue 2, Pages (February 2006)
Volume 15, Issue 5, Pages (May 2016)
A comparison of gene transfer and antigen-loaded dendritic cells for the generation of CD4+ and CD8+ cytomegalovirus-specific T cells in HLA-A2+ and HLA-A2−
David J. Chung, MD, PhD, Katherine B. Pronschinske, Justin A
The Notch Ligands Jagged2, Delta1, and Delta4 Induce Differentiation and Expansion of Functional Human NK Cells from CD34+ Cord Blood Hematopoietic Progenitor.
Volume 33, Issue 4, Pages (October 2010)
CD25 expression distinguishes functionally distinct alloreactive CD4+ CD134+ (OX40+) T-cell subsets in acute graft-versus-host disease  Philip R Streeter,
Volume 38, Issue 3, Pages (March 2013)
Early Vaccination with Tumor Lysate-Pulsed Dendritic Cells after Allogeneic Bone Marrow Transplantation Has Antitumor Effects  Jeffrey S. Moyer, Gabriel.
Dysregulation of Lymphocyte Interleukin-12 Receptor Expression in Sézary Syndrome  Mohamed H. Zaki, Ryan B. Shane, Yuemei Geng, Louise C. Showe, Suzanne.
Robin L. Williams, Sarah Cooley, Veronika Bachanova, Bruce R
Donor and recipient BAL T cells are phenotypically and functionally memory T cells. Donor and recipient BAL T cells are phenotypically and functionally.
Abnormalities of the Bone Marrow Immune Microenvironment in Patients with Prolonged Isolated Thrombocytopenia after Allogeneic Hematopoietic Stem Cell.
by Martin Felices, Behiye Kodal, Peter Hinderlie, Michael F
Presentation transcript:

Cytokine-Induced Memory-Like Differentiation Enhances Unlicensed Natural Killer Cell Antileukemia and FcγRIIIa-Triggered Responses  Julia A. Wagner, Melissa M. Berrien-Elliott, Maximillian Rosario, Jeffrey W. Leong, Brea A. Jewell, Timothy Schappe, Sara Abdel-Latif, Todd A. Fehniger  Biology of Blood and Marrow Transplantation  Volume 23, Issue 3, Pages 398-404 (March 2017) DOI: 10.1016/j.bbmt.2016.11.018 Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 1 Cytokine preactivation enhances the functional response of both licensed and unlicensed NK cells to leukemia targets or cytokine restimulation. (A and D) Naive PBMCs were stimulated with K562 leukemia target cells (A) or IL-12 + IL-15 (D) for 6 hours after which IFN-γ protein levels were assessed via intracellular flow cytometry. Representative data showing the percentage of IFN-γ positive cells from select licensed versus unlicensed NKG2A−CD56dim NK cell subsets and summary data of all IFN-γ positive licensed versus unlicensed NKG2A-CD56dim NK cells from 9 normal donors are shown (7 independent experiments). (B, C, E, F) Memory-like or control NK cells were generated from PBMCs as described in Methods and restimulated with K562 tumor targets (B and C) or IL-12 + IL-15 (E and F) for 6 hours. (B) and (E) show the IFN-γ response of the different NKG2A−CD56dim NK cell subsets according to KIR expression from representative donors in response to K562 targets (B) or cytokines (E). Summary data of the normalized mean ± SEM IFN-γ response of licensed versus unlicensed memory-like or control NK cells from 8 normal donors (6 independent experiments) to K562 targets (C) or cytokines (F) is also shown. Normalization was performed due to expected interindividual differences in absolute IFN-γ percentages: for each donor, data were normalized to the NK cell subset (memory-like/licensed, memory-like/unlicensed, control/licensed, control/unlicensed) with the highest IFN-γ response, which was set at 100%. Green indicates memory-like NK cells; blue, control NK cells; closed circles and bars, licensed NK cells; open CIRCLES and bars, unlicensed NK cells. HLA-B and -C type is indicated for each representative donor. *P < .05, **P < .01, ***P < .001. Biology of Blood and Marrow Transplantation 2017 23, 398-404DOI: (10.1016/j.bbmt.2016.11.018) Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 2 Memory-like NK cells show enhanced responsiveness to FcγRIIIa ligation among both licensed and unlicensed NK cells. (A) Naive PBMC were stimulated with plate-bound anti-FcγRIIIa antibody for 6 hours and analyzed for intracellular IFN-γ production while gating on licensed versus unlicensed NKG2A−CD56dim NK cell subsets as described in Figure 1. Flow cytometry plots of IFN-γ positive cells from select licensed versus unlicensed NKG2A−CD56dim NK subsets from a representative donor and summary data showing the IFN-γ response of all licensed versus unlicensed NKG2A−CD56dim NK cells from 9 normal donors (7 independent experiments) are shown. (B-F) Memory-like and control NK cells were differentiated as described in Methods and restimulated with plate-bound anti-FcγRIIIa antibody (B, E, F) or rituximab-coated Raji lymphoma target cells (C) in a 6-hour functional assay or rituximab-coated Raji lymphoma targets in a 4-hour flow-based killing assay (D). (B and C) Representative flow cytometry data are shown, as well as summary data of mean ± SEM IFN-γ positive memory-like versus control NK cells from 8 to 10 normal donors (n ≥ 4 independent experiments). (D) Memory-like versus control NK cell antibody-dependent cellular cytotoxicity at different effector to target ratios. Con indicates control; mem, memory-like; Ritux, rituximab-coated. Raji cells alone are relatively NK cell resistant, and killing without rituximab did not differ between control and memory-like NK cells. (E) IFN-γ response of the different NKG2A−CD56dim NK cell subsets to plate-bound anti-FcγRIIIa antibody according to KIR expression from a representative donor. (F) Summary data of the normalized mean ± SEM IFN-γ response to plate-bound anti-FcγRIIIa antibody of licensed versus unlicensed memory-like or control NK cells. Normalization was performed as described in Figure 1. GREEN indicates memory-like NK cells; blue, control NK cells ; closed circles and bars, licensed NK cells; open circles and bars, unlicensed NK cells. HLA-B and -C type is indicated for each representative donor. *P < .05, **P < .01, ***P < .001. Biology of Blood and Marrow Transplantation 2017 23, 398-404DOI: (10.1016/j.bbmt.2016.11.018) Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions